Gauss Raises $20 Million in Series C
Gauss Surgical, an AI-driven healthcare technology company, acquired $20 million in Series C funding from Northwell Health and SoftBank Ventures Korea, the global early-stage venture capital arm of SoftBank Group. The LS Polaris Innovation Fund and seven other leading U.S. health systems also participated in the round.
The company’s flagship product, Triton, is designed to monitor surgical blood loss on the iPad in real time using digital imaging and machine learning. It has received de novo approval from the U.S. Food and Drug Administration and a European CE mark. So far, Triton has been adopted by 50 U.S. hospitals, which perform 200,000 infant deliveries each year.
The company plans to use the proceeds of the round to accelerate the adoption of its Triton platform in hospitals and to develop new AI-driven applications for the operating room.